View Older Stories View More Recent Stories

Feb 9, 2021 08:46AM Agenus (AGEN) announced additional confirmed objective clinical responses from its Phase 1/2 trial of AGEN1181
Feb 9, 2021 08:45AM Agenus Announces New Responses for AGEN1181
Feb 9, 2021 08:45AM Agenus Announces New Responses for AGEN1181
Feb 4, 2021 08:32AM Agenus (AGEN) Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
Feb 4, 2021 08:30AM Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
Feb 4, 2021 08:30AM Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
Jan 26, 2021 08:39AM Agenus (AGEN) Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
Jan 26, 2021 08:30AM Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
Jan 26, 2021 08:30AM Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
Jan 19, 2021 12:09PM Agenus to Participate in B. Riley Securities' Oncology Investor Conference
Jan 19, 2021 12:09PM Agenus to Participate in B. Riley Securities' Oncology Investor Conference
Dec 3, 2020 07:45AM Completion of Balstilimab BLA Filing Extended To 1H2021
Dec 3, 2020 07:45AM Completion of Balstilimab BLA Filing Extended To 1H2021
Dec 1, 2020 08:08AM Agenus (AGEN) Reports Launch of Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
Dec 1, 2020 08:00AM Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
Dec 1, 2020 08:00AM Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
Nov 25, 2020 01:28PM Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
Nov 25, 2020 01:28PM Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
Nov 16, 2020 07:04PM Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference
Nov 16, 2020 07:04PM Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference
Nov 13, 2020 02:43PM Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
Nov 13, 2020 02:42PM Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
Nov 12, 2020 09:00AM Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley
Nov 12, 2020 09:00AM Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley
Nov 10, 2020 08:45AM An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
Nov 10, 2020 08:45AM An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
Nov 9, 2020 08:15AM Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020
Nov 9, 2020 08:15AM Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020
Nov 5, 2020 08:00AM Dr. Steven O’Day Named Agenus Chief Medical Officer
Nov 5, 2020 08:00AM Dr. Steven O’Day Named Agenus Chief Medical Officer
Nov 2, 2020 08:45AM Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
Nov 2, 2020 08:45AM Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
Oct 29, 2020 07:45AM Agenus R&D Update & Third Quarter Financial Report
Oct 29, 2020 07:45AM Agenus R&D Update & Third Quarter Financial Report
Oct 20, 2020 10:34AM Agenus to Report Third Quarter Earnings
Oct 20, 2020 10:34AM Agenus to Report Third Quarter Earnings
Oct 14, 2020 05:00PM Agenus to Present on Seven Novel Programs at SITC 2020
Oct 14, 2020 05:00PM Agenus to Present on Seven Novel Programs at SITC 2020
Oct 13, 2020 08:30AM Susan Hirsch Joins Agenus’ Board of Directors
Oct 13, 2020 08:30AM Susan Hirsch Joins Agenus’ Board of Directors
Sep 18, 2020 08:30AM Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer
Sep 18, 2020 08:30AM Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer
Sep 18, 2020 08:29AM Agenus (AGEN) Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer
Sep 18, 2020 06:08AM Agenus (AGEN) Presents Results from Two Large Cervical Cancer Trials at ESMO
Sep 18, 2020 03:00AM Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO
Sep 18, 2020 03:00AM Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO
Sep 17, 2020 05:06PM Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With
Sep 17, 2020 05:06PM Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With
Sep 17, 2020 01:38PM Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline
Sep 17, 2020 01:38PM Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline
View More Recent Stories View Older Stories